AlzeCure Pharma AB Market Cap

AlzeCure Pharma AB has a market cap or net worth of 158.58 million as of April 29, 2026. Its market cap has decreased by -26.09% in one year.

Market Cap

158.58M

Enterprise Value

110.81M

Revenue

n/a

Ranking

n/a

PE Ratio

n/a

Stock Price

1.38

Market Cap Chart

Since November 28, 2018, AlzeCure Pharma AB's market cap has decreased from 415.42M to 158.58M, a decrease of -61.83%. That is a compound annual growth rate of -12.17%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	158.58M	-31.00%
Dec 30, 2025	229.83M	126.34%
Dec 30, 2024	101.54M	-47.41%
Dec 29, 2023	193.09M	-24.88%
Dec 30, 2022	257.04M	14.39%
Dec 30, 2021	224.71M	-34.33%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Diamyd Medical AB	158.08M
Elicera Therapeutics AB	151.67M
Active Biotech AB	175.30M
Alligator Bioscience AB	141.32M
NextCell Pharma AB	132.33M
IRLAB Therapeutics AB	130.63M
Xbrane Biopharma AB	205.64M
Initiator Pharma	214.26M

Market Cap Rankings